# Phase 5C-H ModelCore-equivalent Route Gate

Status: proposed route-definition gate after Phase 5C-G

This phase records `modelcore-equivalent-closure-positive-control` as a
defined-but-unsatisfied route in
`phase5c-post-fidelity-entry-gate-v1`. It incorporates the PR #193 handoff into
the normative gate without implementing a closure, satisfying an entry route,
or changing the inherited no-go.

Machine-readable gate:

```text
data/myocardium/gates/phase5c-post-fidelity-entry-gate-v1.json
```

Required verifier:

```text
npm run verify:myocardium-phase5c-post-fidelity-entry-gate
```

Source no-go evidence:

```text
data/myocardium/protocols/land-new-myocardium-low-preload-phase5c-fidelity-audit-v1.json
```

Closure protocol descriptor:

```text
data/myocardium/protocols/modelcore-equivalent-positive-control-closure-v1.json
```

## Route Set

Entry route ids recorded in the gate:

```text
same-closure-period2-positive-control
modelcore-equivalent-closure-positive-control
owner-approved-replacement-criterion
```

The new route has `status=defined-not-satisfied`. It keeps
`blocked-until-positive-control-period2` as the active advancement state.

Evidence fields for the ModelCore-equivalent route include:

```text
closureProtocolId=modelcore-equivalent-positive-control-closure-v1
closureImplementationStatus=not-implemented
routeSatisfactionStatus=not-satisfied
legacyPositiveControlStatus=period-2-positive-control-pass
positiveControlObservedPeriodBeats=2
sameProtocolOrExplicitEquivalence=true
eventSurfacePreservationRequired=true
sourceProviderDifferenceOnly=true
secondOrderReferenceStillRequired=true
```

Event-surface evidence list: qDot, valve timing, afterload, preload,
TBV/projection, pressure-floor, beat-selection, and sampling behavior preserved
or explicitly matched. The route remains unsatisfied until that evidence exists.

## Boundary

This phase has no runtime replacement, no ModelCore/chamber/case/official-case/
Workbench/state-schema wiring, no qDot/valve/afterload tuning, no Land
parameter tuning, no official morphology acceptance, no final no-alternans, no
calcium-cycling alternans acceptance, no RV pressure-overload coverage, no
ventricular interdependence coverage, no right-heart failure coverage, and no
TriSeg adoption.
